Cardiovascular Disease Doctors in Walla Walla, WA Accepting Medicare

3 Cardiovascular Disease doctors found. Showing 1 - 3

Ronny Y Yu, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1103a S 2nd Ave, Walla Walla, WA 99362 Phone: 509-522-2882    Fax: 509-522-2809

Dr. Suwong Wongsuwan, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St, St Mary Medical Center, Cardiology Suite, Walla Walla, WA 99362 Phone: 509-897-2600    Fax: 509-897-5747

S Steven Maxood, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-522-5731    Fax: 509-522-5747

News Archive

AP looks at USAID administrator vacancy

Although there's "increasing pressure" on President Obama "to fill his administration's vacant top foreign-assistance post ... no candidate is in sight nine months into his term," the Associated Press writes in an article exploring the absence of a leader for USAID. Obama and Secretary of State Hillary Rodham Clinton have expressed a desire for "the agency to play a bigger role in U.S. foreign policy ... [with] more equal roles for diplomacy and development alongside defense," according to the AP.

Alliance HealthCare commences $190 million registered exchange offer

Alliance HealthCare Services, Inc. announced today that it has commenced a registered exchange offer to exchange up to $190 million aggregate principal amount of its 8.00% series B senior notes due 2016 which have been registered under the Securities Act of 1933, as amended, for any and all of its outstanding 8.00% senior notes due 2016 which were issued in a private placement.

Laboratory middleware solution to be exhibited by NoemaLife at this year's AACC

NoemaLife, Europe's leading provider of clinical and hospital software solutions, will exhibit the company's HALIA middleware for clinical chemistry, microbiology and molecular biology labs at this year's AACC (American Association of Clinical Chemists) Annual Meeting (15-19 July 2012, Los Angeles, CA).

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.

Read more Medical News

› Verified 2 days ago